Hyperaluminemia During Long-term Dialysis: Still Relevant Today

Slides:

Advertisements

Similar presentations

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.

Advertisements

Renal Function Testing

KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,

Diagnosis and Treatment of Hyponatremia

Safety and Efficacy of Incretin-Based Therapies in Patients With Type 2 Diabetes Mellitus and CKD: A Systematic Review and Meta-analysis Patricia M.

Peritoneal dialysis American Journal of Kidney Diseases

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc

Regional Differences in the Associations Between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the Dialysis Outcomes and.

Quiz Page March 2008 American Journal of Kidney Diseases

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

Empirically Derived Search Filters for the Development of Kidney Disease Clinical Practice Guidelines Pavel S. Roshanov, MD, MSc, Arthur V. Iansavichus,

A Decade After the KDOQI CKD Guidelines

Joseph A. Vassalotti, MD, Beth Piraino, MD, Lynda A. Szczech, MD

Quiz Page November 2016 American Journal of Kidney Diseases

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

What Is the Goal With Endogenous Filtration Markers—Estimation of GFR or Prediction of Kidney Outcomes? Andrew D. Rule, MD, MSc, Kent R. Bailey, PhD,

Sevelamer Prescriptions After Reporting of the Dialysis Clinical Outcomes Revisited (DCOR) Trial Findings: An Analysis of 5,495 Patients Receiving Maintenance.

Evaluation of the Potential Living Kidney Donor

Hai-yan Wang, MD, American Journal of Kidney Diseases

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Wayne Trebbin, MD, Peter Monteleone, MD

Salt and Hypertension American Journal of Kidney Diseases

Karl D. Nolph, MD, American Journal of Kidney Diseases

Effect of Protein Restriction on Serum and Urine Phosphate in the Modification of Diet in Renal Disease (MDRD) Study Britt Newsome, MD, Joachim H. Ix,

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Dorothea Nitsch, MD, MSc American Journal of Kidney Diseases

Calcium-Alkali Syndrome Due to Vitamin D Administration and Magnesium Oxide Administration Shigeru Hanada, MD, Mari Iwamoto, MD, Namiko Kobayashi, MD,

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

A Decade After the KDOQI CKD Guidelines: A Historical Perspective

David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD

Proteinuria and Other Urinary Biomarkers in Kidney Transplantation: Why Are We Still Waiting for Godot? Bertram L. Kasiske, MD American Journal of Kidney.

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Michael Copland, MD, Paul Komenda, MD, Eric D

Sankar D. Navaneethan, MD, MPH, Suetonia C. Palmer, MBChB, Jonathan C

Julie A. Wright Nunes, MD, MPH, Kerri L

Polyunsaturated Fatty Acids and Kidney Disease

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Kidney Disease Among African Americans: A Population Perspective

Nephrology: As It Was Then, But Is Not Now

Quiz Page April 2008 American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

Evidence and Outcomes in CKD

Drug Dose Adjustments in Patients With Renal Impairment

Dennis G. Moledina, MD, Mark A. Perazella, MD

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

George L. Bakris, MD, John M. Burkart, MD, Eric D

Thiazide Responsiveness Testing in Patients With Renal Magnesium Wasting and Correlation With Genetic Analysis: A Diagnostic Test Study Anneke P. Bech,

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Arnold S. Relman, MD, American Journal of Kidney Diseases

Trial Quality in Nephrology: How Are We Measuring Up?

Removal of Dabigatran by Hemodialysis

Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm David P. Calfee, MD, MS American Journal of Kidney.

Making Music American Journal of Kidney Diseases

Ronald L. Pisoni, PhD, MS, Brenda W. Gillespie, PhD, David M

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Quiz Page June 2009 American Journal of Kidney Diseases

James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD

Quiz Page June 2011 American Journal of Kidney Diseases

Jordi Goldstein-Fuchs, DSc, RD, RN, Denis Fouque, MD, PhD

This Month in AJKD American Journal of Kidney Diseases

Extracorporeal Treatment for Barbiturate Poisoning: Recommendations From the EXTRIP Workgroup Robert Mactier, MD, Martin Laliberté, MD, MSc, Joelle Mardini,

Dialysis Research and N-of-1 Trials: Made for Each Other?

Quiz Page January 2010 American Journal of Kidney Diseases

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

Maristela Böhlke, PhD American Journal of Kidney Diseases

A Decade After the KDOQI CKD Guidelines: Impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Adam Whaley-Connell, DO, MSPH

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Quiz page December 2003 American Journal of Kidney Diseases

Presentation transcript:

Hyperaluminemia During Long-term Dialysis: Still Relevant Today Megan Christie, BSc, Valery Lavergne, MD, MSc, Tabo Sikaneta, MD, Corinne Seng Hue, PhD, Hulya Taskapan, MD, Paul W. Tam, MD, Paul Ayoub, MD, Robert Ting, MD, Denise Leblanc, Marc Ghannoum, MD American Journal of Kidney Diseases Volume 58, Issue 5, Pages 861-863 (November 2011) DOI: 10.1053/j.ajkd.2011.08.008 Copyright © 2011 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Lowess curve of serum aluminum (Al) levels over time. Solid grey lines represent 95% confidence intervals. Note: Conversion factors for serum aluminum in μg/L to μmol/L, ×0.0371. Abbreviation: KDOQI, Kidney Disease Outcomes Quality Initiative. American Journal of Kidney Diseases 2011 58, 861-863DOI: (10.1053/j.ajkd.2011.08.008) Copyright © 2011 National Kidney Foundation, Inc. Terms and Conditions